Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
about
MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.A comparative study on the complications of conventional and end-to-side inserting pancreatojejunostomy after pancreaticoduodenectomy.The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Safety and efficacy of postoperative pharmacologic thromboprophylaxis with enoxaparin after pancreatic surgery.Significance of lymph node metastasis in pancreatic neuroendocrine tumor.A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma.
P2860
Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
@en
type
label
Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
@en
prefLabel
Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
@en
P2093
P2860
P1433
P1476
Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
@en
P2093
Akira Chikamoto
Daisuke Hashimoto
Hideo Baba
Hidetoshi Nitta
Hirohisa Okabe
Hiromitsu Hayashi
Katsunobu Taki
Kota Arima
Risa Inoue
Takaaki Higashi
P2860
P304
P356
10.1007/S00595-015-1238-8
P577
2015-08-25T00:00:00Z